April 14, 2025

FDA-Approved COVID-19 Drugs: Safety Risks Assessed

Researchers found most FDA-authorized COVID-19 treatments were not linked to serious adverse events, though risks may rise with tocilizumab or convalescent plasma in specific patients.

Conexiant

April 11, 2025

Early Antibiotics Linked to Asthma, Eczema

Researchers found early-life antibiotic use was linked to increased risk of asthma and eczema, but not most other immune diseases, after adjusting for familial factors.

Conexiant

April 08, 2025

Study Investigates Efficacy of Baricitinib Tapering

Most patients maintained control of disease activity after tapering baricitinib, according to the RA-BEYOND study.

Conexiant

April 02, 2025

Ultraprocessed Foods Linked to Arthritis Risk

"Each 10-percentage point higher %TEI from UPFs was associated with a 4% higher likelihood of having any type of arthritis," researchers noted.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

RA and axSpA Tied to Depression, Anxiety in Large Study

Individuals with autoimmune arthritides are more likely to experience mood and anxiety disorders—even relative to counterparts with other chronic illnesses—according to a national cohort study.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 25, 2025

Not All Plant-Based Diets Are Equal

Higher adherence to a healthy plant-based diet linked to lower IBD risk.

Conexiant

March 24, 2025

TPT Lowers Tuberculosis Risk in Rheumatic Patients

TPT decreased the overall risk of tuberculosis disease in patients with rheumatic diseases, with a 76% risk reduction observed in certain subgroups, researchers reported.

Conexiant